L-Cysteine Hydrochloride (Sandoz Inc)


Welcome to the PulseAid listing for the L-Cysteine Hydrochloride drug offered from Sandoz Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: L-Cysteine Hydrochloride
SUBSTANCE NAME: CYSTEINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2016-06-14
END MARKETING DATE: 0000-00-00


L-Cysteine Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionL-Cysteine Hydrochloride from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 2016-06-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-8940_40e63e07-1f05-4dd9-af32-d40cbfb463e5
PRODUCT NDC: 0781-8940
APPLICATION NUMBER:

Other CYSTEINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sandoz IncL-Cysteine Hydrochloride